Total Payments
$24,873
2024 Payments
$1,817
Companies
30
Transactions
229
Medicare Patients
5,639
Medicare Billing
$377,196
Payment Breakdown by Category
Food & Beverage$13,819 (55.6%)
Consulting$9,260 (37.2%)
Travel$1,302 (5.2%)
Education$439.89 (1.8%)
Other$51.89 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,819 | 208 | 55.6% |
| Consulting Fee | $9,260 | 2 | 37.2% |
| Travel and Lodging | $1,302 | 5 | 5.2% |
| Education | $439.89 | 13 | 1.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $51.89 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $8,585 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $4,186 | 30 | $0 (2024) |
| ABBVIE INC. | $3,473 | 37 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,224 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,183 | 30 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $873.45 | 8 | $0 (2022) |
| Genentech USA, Inc. | $603.62 | 15 | $0 (2022) |
| PFIZER INC. | $602.93 | 8 | $0 (2024) |
| Incyte Corporation | $495.02 | 4 | $0 (2024) |
| Galderma Laboratories, L.P. | $480.12 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,817 | 17 | Janssen Biotech, Inc. ($336.83) |
| 2023 | $1,882 | 22 | AbbVie Inc. ($694.46) |
| 2022 | $1,856 | 17 | ABBVIE INC. ($566.76) |
| 2021 | $709.45 | 7 | AbbVie Inc. ($203.81) |
| 2020 | $359.97 | 3 | Janssen Biotech, Inc. ($125.00) |
| 2019 | $1,777 | 19 | AbbVie, Inc. ($578.81) |
| 2018 | $10,144 | 54 | GENZYME CORPORATION ($7,606) |
| 2017 | $6,328 | 90 | Janssen Biotech, Inc. ($3,513) |
All Payment Transactions
229 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $81.28 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $122.40 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $116.03 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $118.74 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $120.87 | General |
| Category: Dermatology | ||||||
| 08/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $83.02 | General |
| Category: Immunology | ||||||
| 08/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $116.22 | General |
| Category: Immunology | ||||||
| 06/29/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $77.85 | General |
| 06/18/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $92.78 | General |
| Category: Inflammation & Immunology | ||||||
| 05/23/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $122.55 | General |
| Category: Dermatology | ||||||
| 05/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $123.27 | General |
| Category: Immunology | ||||||
| 05/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $87.72 | General |
| Category: IMMUNOLOGY | ||||||
| 05/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $77.47 | General |
| Category: Immunology | ||||||
| 05/02/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $123.36 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $121.61 | General |
| Category: Immunology | ||||||
| 02/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $133.30 | General |
| Category: Immunology | ||||||
| 12/05/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/30/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $122.55 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $87.38 | General |
| 11/07/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $82.82 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $125.85 | General |
| Category: Dermatology | ||||||
| 09/20/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $128.80 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $122.40 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $97.77 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,140 | 2,744 | $546,791 | $84,025 |
| 2022 | 14 | 1,052 | 2,527 | $471,680 | $77,854 |
| 2021 | 16 | 1,695 | 3,899 | $681,660 | $116,658 |
| 2020 | 19 | 1,752 | 4,317 | $629,096 | $98,659 |
Total Patients
5,639
Total Services
13,487
Medicare Billing
$377,196
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 66 | 940 | $1,880 | $756.26 | 40.2% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2022 | 13 | 13 | $6,417 | $709.24 | 11.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 11 | 16 | $4,955 | $621.11 | 12.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 484 | 771 | $224,880 | $50,976 | 22.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 139 | 139 | $53,875 | $11,140 | 20.7% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 139 | 149 | $81,918 | $10,058 | 12.3% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 99 | 117 | $70,784 | $9,192 | 13.0% |
| 17000 | Destruction of skin growth | Office | 2021 | 191 | 233 | $82,773 | $8,731 | 10.5% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 46 | 49 | $33,523 | $4,516 | 13.5% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2021 | 23 | 26 | $24,986 | $3,448 | 13.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 72 | 90 | $15,792 | $3,374 | 21.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 32 | $13,600 | $3,232 | 23.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 112 | 261 | $19,938 | $2,743 | 13.8% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 124 | 444 | $14,880 | $2,178 | 14.6% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 33 | 45 | $12,926 | $1,882 | 14.6% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 44 | 44 | $11,662 | $1,752 | 15.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 125 | 1,456 | $2,912 | $1,457 | 50.0% |
| 69100 | Biopsy of ear | Office | 2021 | 18 | 18 | $9,691 | $1,105 | 11.4% |
| 11900 | Injection of up to 7 skin growths | Office | 2021 | 17 | 25 | $7,520 | $874.04 | 11.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 344 | 534 | $137,411 | $28,860 | 21.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 200 | 320 | $49,600 | $10,168 | 20.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 127 | 137 | $72,191 | $8,639 | 12.0% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 98 | 115 | $67,593 | $7,871 | 11.6% |
| 17000 | Destruction of skin growth | Office | 2020 | 158 | 210 | $73,180 | $7,509 | 10.3% |
| 11104 | Punch biopsy of single skin lesion | Office | 2020 | 66 | 71 | $47,092 | $6,373 | 13.5% |
About Dr. Douglas Robins, MD
Dr. Douglas Robins, MD is a Dermatology healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1265422729.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Robins, MD has received a total of $24,873 in payments from pharmaceutical and medical device companies, with $1,817 received in 2024. These payments were reported across 229 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($13,819).
As a Medicare-enrolled provider, Robins has provided services to 5,639 Medicare beneficiaries, totaling 13,487 services with total Medicare billing of $377,196. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Jacksonville, FL
- Active Since 10/26/2005
- Last Updated 01/11/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1265422729
Products in Payments
- DUPIXENT (Drug) $7,891
- COSENTYX (Biological) $1,039
- Humira (Biological) $1,018
- RINVOQ (Biological) $973.45
- DUPIXENT (Biological) $906.48
- TREMFYA (Drug) $788.64
- SKYRIZI (Biological) $587.15
- Erivedge (Biological) $544.07
- OPZELURA (Drug) $495.02
- STELARA (Biological) $415.35
- Skyrizi (Biological) $397.43
- LIBTAYO (Biological) $359.21
- EPIDUO FORTE (Drug) $332.14
- Tremfya (Drug) $321.25
- DUPIXENT DUPILUMAB INJECTION (Biological) $316.76
- EUCRISA (Drug) $311.79
- TALTZ (Drug) $242.77
- Bimzelx (Biological) $241.77
- Enbrel (Biological) $227.33
- Sotyktu (Drug) $218.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Jacksonville
Dr. Pearl Kwong, Md Phd, MD PHD
Dermatology — Payments: $2.8M
Dermatology $2.8M
Michael Bernhardt, Md, MD
Dermatology — Payments: $702,961
Dermatology $702,961
Kristen Stewart, M.d, M.D
Dermatology — Payments: $107,300
Dermatology $107,300
Jason Sluzevich, Md, MD
Dermatology — Payments: $61,523
Dermatology $61,523
Jean Mcclintock, Md, MD
Dermatology — Payments: $14,036
Dermatology $14,036
John Morello, M.d, M.D
Dermatology — Payments: $12,575
Dermatology $12,575